Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, encouraging affected investors to participate in a class action lawsuit [4][6]. Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false and misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [6]. - Specific allegations include the omission of false rumors and artificial trading activity that inflated the stock price, leading to materially misleading public statements about the company's business and prospects [6]. Group 2: Stock Performance - Pomdoctor's stock experienced a significant decline, dropping from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, representing a decline of roughly $0.12 per share or approximately 24% in a single trading session [7]. - This decline was attributed to heightened volatility and selling pressure amid broader investor concerns regarding the company's financial performance and valuation [7]. Group 3: Class Action Details - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Pomdoctor is April 13, 2026 [4]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will direct and oversee the litigation on behalf of the class [8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Richtech Robotics Inc. due to allegations of false and misleading statements regarding a supposed collaboration with Microsoft, which has led to significant stock losses for investors [4][6]. Group 1: Legal Investigation - Faruqi & Faruqi is reminding investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Richtech [4]. - The complaint alleges that Richtech and its executives violated federal securities laws by making false claims about their relationship with Microsoft [6]. Group 2: Stock Performance - On January 29, 2026, Richtech's stock fell by $1.06, or 20.87%, closing at $4.02, following a critical report questioning the company's Microsoft collaboration [7]. Group 3: Investor Communication - The firm encourages anyone with information regarding Richtech's conduct, including whistleblowers and former employees, to contact them for further investigation [9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Snowflake Inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements about product efficiency and revenue expectations [4][6]. Group 1: Legal Investigation - The law firm is encouraging investors who purchased Snowflake securities between June 27, 2023, and February 28, 2024, to discuss their legal rights [1][4]. - A federal securities class action has been filed against Snowflake, with a deadline of April 27, 2026, for investors to seek the role of lead plaintiff [4][9]. Group 2: Allegations Against Snowflake - The complaint alleges that Snowflake and its executives made false or misleading statements and failed to disclose that product efficiency gains and tiered storage pricing would negatively impact consumption and revenues [6]. - On February 28, 2024, Snowflake disclosed financial results that included forecasts of increased revenue headwinds due to these factors, which led to a significant drop in stock price [7][8]. Group 3: Stock Price Impact - Following the negative news on February 28, 2024, Snowflake's Class A common stock fell by $41.72, or 18.14%, closing at $188.28 per share [8].

Core Viewpoint - Ultragenyx Pharmaceuticals is facing a federal securities class action lawsuit due to allegations of misleading statements regarding the efficacy of its drug setrusumab in treating Osteogenesis Imperfecta, leading to significant stock price declines [4][6][8]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi, LLP is investigating potential claims against Ultragenyx and has set an April 6, 2026 deadline for investors to seek the role of lead plaintiff in the class action [4]. - The lawsuit alleges that Ultragenyx and its executives violated federal securities laws by making false statements about the reliability of data from the Phase III Orbit study [6]. - Investors who purchased Ultragenyx securities between August 3, 2023, and December 26, 2025, are encouraged to discuss their legal rights with the law firm [1][4]. Group 2: Study Results and Stock Impact - On July 9, 2025, Ultragenyx disclosed that the Phase III Orbit study did not achieve statistical significance for its second interim analysis, resulting in a stock price drop of over 25% [7]. - Following a December 29, 2025 announcement that both the Phase III Orbit and Cosmic studies failed to meet primary endpoints, Ultragenyx's stock fell more than 42% [8][9]. - The company attributed the study failures to a low fracture rate in the placebo group and a trend that did not reach statistical significance [8].

Core Viewpoint - Bath & Body Works, Inc. is facing a federal securities class action due to allegations of misleading statements and failure to disclose critical information regarding its business strategy and financial performance [1][2] Summary by Relevant Sections Company Performance - Bath & Body Works reported a 1% year-over-year decline in revenue for Q3 2025, missing prior guidance of 1-3% growth [1] - The company experienced a 26% drop in net income, reporting $77 million [1] - Full-year earnings per diluted share guidance was sharply reduced from a range of $3.28 to $3.53 to "at least $2.83" [1] Business Strategy - The company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow its customer base and did not deliver the expected growth in net sales [1] - As the strategy faltered, Bath & Body Works relied on brand collaborations to mask weak financial results [1] - The company acknowledged that its previous focus on collaborations led to reduced investment in core categories and an overreliance on promotions [1] Legal Proceedings - A lead plaintiff is being sought for the class action, with a deadline of March 16, 2026, for investors who suffered significant losses [1] - The law firm Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works and encourages individuals with relevant information to come forward [1][2]

Core Viewpoint - A class action lawsuit has been filed against Varonis Systems, Inc. for allegedly misleading investors regarding its customer conversion capabilities during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Varonis securities from February 4, 2025, to October 28, 2025 [1]. - Investors have until March 9, 2026, to seek appointment as lead plaintiff representatives [2]. - The allegations state that Varonis and its executives raised investor expectations while being aware that the company was not effectively positioned to convert existing customers to its SaaS offerings, leading to reduced annual recurring revenue (ARR) growth potential [3]. Group 2: Stock Performance Impact - Following the revelation of the true state of customer renewals and conversions, Varonis' stock price fell from $63.00 per share on October 28, 2025, to $32.34 per share on October 29, 2025, marking a decline of $30.66 per share, or over 48% in one day [4].

Group 1 - A class action lawsuit has been filed against Richtech Robotics Inc. on behalf of investors who purchased securities during the period from January 27, 2026, to January 29, 2026 [1][2] - Richtech Robotics specializes in the design and manufacture of AI-driven service robots for industries such as hospitality, healthcare, and manufacturing [2] - The lawsuit alleges that Richtech falsely characterized its relationship with Microsoft as a "hands-on collaboration" instead of a standard customer relationship, leading to a significant decline in share value when the truth was revealed [3] Group 2 - Investors who purchased Richtech securities during the class period have until April 3, 2026, to seek appointment as lead plaintiff representative [2] - Berger Montague, the law firm handling the case, has a strong track record in complex civil litigation and has recovered over $50 billion for clients over its 55-year history [5]

Core Viewpoint - A class action securities lawsuit has been filed against PayPal Holdings, Inc. on behalf of investors who suffered losses due to alleged securities fraud between February 25, 2025, and February 2, 2026 [1] Group 1: Lawsuit Details - The lawsuit claims that PayPal's management provided misleading information regarding the company's financial targets for 2027 and the growth potential of its Branded Checkout segment [1] - Defendants allegedly concealed material adverse facts about PayPal's salesforce capabilities, suggesting that the company was overly optimistic about its growth potential [1] Group 2: Financial Performance - On February 3, 2026, PayPal reported disappointing fourth-quarter and full fiscal year 2025 earnings, revealing a decline in Branded Checkout performance [1] - The company also announced a sudden transition in its CEO role and withdrew its previously stated 2027 financial targets, indicating a slowdown in growth expectations [1] - Following the announcement, PayPal's stock price dropped from $52.33 per share on February 2, 2026, to $41.70 per share on February 3, 2026, marking a decline of approximately 20.31% in one day [1] Group 3: Next Steps for Investors - Investors who experienced losses during the relevant period have until April 20, 2026, to request to be appointed as lead plaintiff in the class action [1] - Participation in the lawsuit does not require any out-of-pocket costs for class members [1]

Core Viewpoint - Lakeland Industries, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between December 1, 2023, and December 9, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Lakeland Industries made false statements and concealed significant issues with its Pacific Helmets and Jolly businesses, including shipping delays and production problems [1] - Defendants allegedly overstated the positive impact of these businesses on Lakeland's financial results and the overall strength of their operations [1] - The complaint indicates that Lakeland's business and financial results were deteriorating due to tariff-related challenges, certification delays, and material flow issues in acquired businesses [1] Group 2: Financial Guidance and Public Statements - The lawsuit asserts that the defendants overstated the effectiveness of their tariff mitigation measures and M&A strategy, leading to unreliable financial guidance [1] - As a result of the aforementioned issues, the public statements made by the defendants were materially false and misleading throughout the relevant period [1] Group 3: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until April 24, 2026, to request appointment as lead plaintiff in the lawsuit [1] - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [1]

Core Viewpoint - A class action securities lawsuit has been filed against Bath & Body Works, Inc. for alleged securities fraud affecting investors between June 4, 2024, and November 9, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [1] - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak underlying financial results [1] - The complaint states that the company was unlikely to meet its previously issued financial guidance, and that positive statements made by the defendants about the company's business were materially misleading [1] Group 2: Investor Information - Investors who suffered losses during the relevant time frame have until March 13, 2026, to request to be appointed as lead plaintiff [1] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [1] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1]